NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 109 filers reported holding NURIX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,359,000 | -9.6% | 1,922,549 | 0.0% | 9.96% | +36.3% |
| Q1 2022 | $26,935,000 | -61.6% | 1,922,549 | -20.6% | 7.31% | -58.4% |
| Q4 2021 | $70,133,000 | -3.4% | 2,422,549 | 0.0% | 17.55% | +27.4% |
| Q3 2021 | $72,580,000 | -20.1% | 2,422,549 | -29.2% | 13.78% | -13.1% |
| Q2 2021 | $90,800,000 | -35.2% | 3,422,549 | -24.1% | 15.85% | -10.6% |
| Q1 2021 | $140,164,000 | -21.4% | 4,508,333 | -16.9% | 17.73% | +15.8% |
| Q4 2020 | $178,293,000 | -5.8% | 5,422,549 | 0.0% | 15.31% | -3.7% |
| Q3 2020 | $189,301,000 | – | 5,422,549 | – | 15.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |